Parabacteroides timonensis

Information

Microbe Identification

Parabacteroides timonensis

Microbe id: PMDBM2021655
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Parabacteroides timonensis [1871013]
Taxonomy Genus: Parabacteroides [375288]
Taxonomy Family: Tannerellaceae [2005525]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Parabacteroides timonensis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Parabacteroides timonensis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Parabacteroides timonensis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Parabacteroides timonensis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Parabacteroides timonensis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗3.84975699146474mNGS
Kidney Failure, Chronic PRJNA648014🔗4.184747814490716S
Hypertension PRJNA509999🔗4.63565641153011mNGS
Diabetes Mellitus, Type 2 PRJNA646010🔗3.4781740761665116S
Brain Neoplasms PRJNA626591🔗4.3143820544979116S
Diarrhea PRJNA317326🔗3.6192642190382316S
Diarrhea PRJEB14038🔗3.91538305046434mNGS
Dwarfism PRJNA819198🔗4.1244161085321616S
Colorectal Neoplasms PRJEB53415🔗3.3879001487638916S
Colorectal Neoplasms PRJNA888860🔗3.92056686332615mNGS
Colorectal Neoplasms PRJNA763023🔗3.99955728706708mNGS
Colorectal Neoplasms PRJNA731589🔗4.26574015828316mNGS
Diabetes Mellitus, Type 1 PRJNA604850🔗3.8831010181504mNGS
Diabetes Mellitus, Type 1 PRJNA871997🔗4.0493059874279516S
Glioma PRJNA626591🔗4.1291916163700916S
Parkinson Disease PRJEB59350🔗3.88740693013299mNGS
Parkinson Disease PRJNA588035🔗4.13132894542557mNGS
Parkinson Disease PRJNA762484🔗4.13426513783402mNGS
Colitis, Ulcerative PRJNA993675🔗-3.5068767209818mNGS
Colitis, Ulcerative PRJNA820056🔗2.3694899938779316S
Spinal Cord Injuries PRJNA669472🔗-3.0460191092435416S
Spinal Cord Injuries PRJNA861246🔗4.5818781853447316S
Hepatitis B, Chronic PRJNA872871🔗-3.9015680530805716S
Carcinoma, Hepatocellular PRJNA872871🔗-4.0573023263816116S
Esophageal Neoplasms PRJNA698746🔗4.1330816957391216S
Celiac Disease PRJNA890948🔗-3.9502622103999516S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.8974775775051216S
Asthma PRJEB23348🔗-3.9838778829589816S
Leukemia, Myeloid, Acute PRJNA813705🔗3.81336269247161mNGS
Crohn Disease PRJNA917086🔗-4.1296864791215416S
Crohn Disease PRJNA993675🔗-3.54672588539003mNGS
Crohn Disease PRJNA398089🔗3.64151424532708mNGS
Psoriasis PRJNA938297🔗-3.08441337898956mNGS
Polycystic Ovary Syndrome PRJNA530971🔗3.57928981412066mNGS
Schistosomiasis haematobia PRJNA526732🔗-3.0948302898823216S
Meningioma PRJNA626591🔗4.0777143522706816S
Diabetic Retinopathy PRJNA857030🔗4.2329516948554816S
Arthritis, Rheumatoid PRJNA896336🔗-4.15269699797303mNGS
Arthritis, Rheumatoid PRJNA786110🔗-4.0690353274037616S
Arthritis, Rheumatoid PRJNA753264🔗4.1575956605970516S
Nephrotic Syndrome PRJNA800189🔗-4.2544938002029216S
Cholangiocarcinoma PRJNA932948🔗-3.6034999806551mNGS
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗3.0670576700368216S
Hepatitis C PRJNA328966🔗-4.223326253401416S
Hepatitis C PRJNA1070593🔗-3.8420242108243516S
Clostridium Infections PRJNA648321🔗-4.04010550801212mNGS
Pancreatic Neoplasms PRJNA665854🔗4.18681316427495mNGS
Liver Diseases, Alcoholic PRJNA540738🔗3.9563336092493616S
Liver Cirrhosis PRJNA872871🔗-4.1369871292262416S
Liver Cirrhosis PRJNA861246🔗4.3649544380076716S
Cystic Fibrosis PRJNA314903🔗-3.97739357684943mNGS
Obesity PRJNA1125836🔗4.23881075241116mNGS
Diabetes Mellitus PRJNA774037🔗4.1443435271628916S
Inflammatory Bowel Diseases PRJNA993675🔗-4.00328990407174mNGS
Rhinitis, Allergic PRJNA718687🔗-3.9329256942413416S
Renal Insufficiency, Chronic PRJNA562327🔗4.3097163307470516S
Renal Insufficiency, Chronic PRJNA949558🔗4.3520855823489116S
Fibromyalgia PRJNA521587🔗3.86621621322719mNGS
Breast Neoplasms PRJNA658160🔗3.8628711273427316S
COVID-19 PRJNA689961🔗4.27114372194094mNGS
COVID-19 PRJNA769052🔗4.4501968792479116S
COVID-19 PRJNA624223🔗4.82614301280138mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Parabacteroides timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Parabacteroides timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Parabacteroides timonensis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Parabacteroides timonensis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Parabacteroides timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Parabacteroides timonensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Parabacteroides timonensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Parabacteroides timonensis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Parabacteroides timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Parabacteroides timonensis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Parabacteroides timonensis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?